Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 35776 - 35800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Domperidone	Approved Investigational Vet Approved	CYP1A1	1543	upregulated	Domperidone results in increased expression of CYP1A1 mRNA	15q24.1	A21062
Dopamine	Approved Investigational	BBC3	27113	upregulated	[Dopamine results in increased expression of HIF1A protein] which results in increased expression of BBC3 mRNA	19q13.32	A22408
Dopamine	Approved Investigational	BNIP3	664	upregulated	[Dopamine results in increased expression of HIF1A protein] which results in increased expression of BNIP3 mRNA	10q26.3	A22408
Dopamine	Approved Investigational	PCMT1	5110	downregulated	Dopamine results in decreased expression of PCMT1 mRNA	6q25.1	A22409
Dopamine	Approved Investigational	SLC25A14	9016	upregulated	Dopamine results in increased expression of SLC25A14 mRNA	Xq26.1	A22410
Doramectin	Experimental Vet Approved	ABCB1	5243	downregulated	doramectin results in decreased expression of ABCB1 mRNA	7q21.12	A22411
Doxazosin	Approved Investigational	CDKN1A	1026	upregulated	Doxazosin results in increased expression of CDKN1A mRNA	6p21.2	A22412
Doxazosin	Approved Investigational	FASLG	356	upregulated	Doxazosin results in increased expression of FASLG mRNA	1q24.3	A22412
Doxazosin	Approved Investigational	KLF10	7071	upregulated	Doxazosin results in increased expression of KLF10 mRNA	8q22.3	A22412
Doxazosin	Approved Investigational	NFKBIA	4792	upregulated	Doxazosin results in increased expression of NFKBIA mRNA	14q13.2	A22412
Doxazosin	Approved Investigational	SMAD4	4089	upregulated	Doxazosin results in increased expression of SMAD4 mRNA	18q21.2	A22412 A22413
Doxazosin	Approved Investigational	VEGFA	7422	downregulated	Doxazosin results in decreased expression of VEGFA mRNA	6p21.1	A22414
Doxazosin	Approved Investigational	VEGFA	7422	downregulated	Doxazosin results in decreased expression of VEGFA mRNA alternative form	6p21.1	A22413
Doxepin	Approved Investigational	ASNS	440	upregulated	Doxepin results in increased expression of ASNS mRNA	7q21.3	A20646
Doxepin	Approved Investigational	FABP1	2168	upregulated	Doxepin results in increased expression of FABP1 mRNA	2p11.2	A20646
Doxepin	Approved Investigational	GDPD3	79153	upregulated	Doxepin results in increased expression of GDPD3 mRNA	16p11.2	A20646
Doxepin	Approved Investigational	INHBE	83729	upregulated	Doxepin results in increased expression of INHBE mRNA	12q13.3	A20646
Doxepin	Approved Investigational	LSS	4047	upregulated	Doxepin results in increased expression of LSS mRNA	21q22.3	A20646
Doxepin	Approved Investigational	NUPR1	26471	upregulated	Doxepin results in increased expression of NUPR1 mRNA	16p11.2	A20646
Doxepin	Approved Investigational	SERPINA3	12	upregulated	Doxepin results in increased expression of SERPINA3 mRNA	14q32.13	A20646
Doxepin	Approved Investigational	SLC2A3	6515	downregulated	Doxepin results in decreased expression of SLC2A3 mRNA	12p13.31	A20646
Doxepin	Approved Investigational	TAGLN	6876	downregulated	Doxepin results in decreased expression of TAGLN mRNA	11q23.2	A20646
Doxorubicin	Approved Investigational	ABCA2	20	upregulated	Doxorubicin results in increased expression of ABCA2 mRNA	9q34.3	A22415
Doxorubicin	Approved Investigational	ABCA3	21	upregulated	Doxorubicin results in increased expression of ABCA3 mRNA	16p13.3	A22415
Doxorubicin	Approved Investigational	ABCB1	5243	upregulated	Doxorubicin results in increased expression of ABCB1 mRNA	7q21.12	A22416 A22417 A22418 A22419 A22420 A22421 A22422

Displaying entries 35776 - 35800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability